StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71−0.17 (-9.04%)

Close on Nov 20, 2026Market cap $2.72MP/E –Yield –

Silo Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Silo Pharma's gross profit for the twelve months ending Jun 30, 2026 was -$7.99K, down 112.1% year over year. For fiscal 2025 it was $27.81K, down 58.0% from the year before. The highest annual figure on record is $66.26K in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.81K-58.0%
FY2024Dec 31, 2024$66.26K0.0%
FY2023Dec 31, 2023$66.26K0.0%
FY2022Dec 31, 2022$66.26K+0.0%
FY2021Dec 31, 2021$66.26K–
FY2020Dec 31, 2020-$135.20K-1125.7%
FY2019Dec 31, 2019$13.18K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026-$2.66K-116.1%
Q4 FY2025Dec 31, 2025-$2.66K-116.1%
Q3 FY2025Sep 30, 2025-$2.66K-116.1%
Q2 FY2025Jun 30, 2025$16.57K0.0%
Q1 FY2025Mar 31, 2025$16.57K-50.0%
Q4 FY2024Dec 31, 2024$16.57K0.0%
Q3 FY2024Sep 30, 2024$16.57K0.0%
Q4 FY2023Dec 31, 2023$16.57K0.0%
Q1 FY2023Jun 30, 2023$33.13K+100.0%
Q4 FY2022Dec 31, 2022$16.57K0.0%
Q3 FY2022Sep 30, 2022$16.57K0.0%
Q2 FY2022Jun 30, 2022$16.57K0.0%
Q1 FY2022Mar 31, 2022$16.57K+0.0%
Q4 FY2021Dec 31, 2021$16.57K–
Q3 FY2021Sep 30, 2021$16.57K–
Q2 FY2021Jun 30, 2021$16.57K+1776.1%
Q1 FY2021Mar 31, 2021$16.56K+7787.1%
Q4 FY2020Dec 31, 2020-$123.13K-1047.5%
Q3 FY2020Sep 30, 2020-$13.16K-7177.4%
Q2 FY2020Jun 30, 2020$883–
Q1 FY2020Mar 31, 2020$210–
Q4 FY2019Dec 31, 2019$13.00K–
Q3 FY2019Sep 30, 2019$186–

More Silo Pharma figures

See a number that looks wrong?